BURLINGAME, Calif.--(BUSINESS WIRE)--Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines and immunotherapeutics for infectious diseases and cancer, today announced the achievement of a milestone event in its licensing agreement with Bayer HealthCare’s Animal Health Division for the evaluation of Juvaris’ technology for applications in animal health markets.
